Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 8/20 | 0.85 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.85 |
| ▸ | HIF1A | Q16665 | 7/20 | 0.85 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.85 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.85 |
| ▸ | PGR | P06401 | 3/20 | 0.85 |
| ▸ | TSHR | P16473 | 2/20 | 0.85 |
| ▸ | AR | P10275 | 2/20 | 0.85 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.85 |
| ▸ | MEN1 | O00255 | 1/20 | 0.85 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.85 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.85 |
| ▸ | APEX1 | P27695 | 1/20 | 0.85 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.85 |
| ▸ | IKBKB | O14920 | 1/20 | 0.85 |
| ▸ | CHUK | O15111 | 1/20 | 0.85 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.85 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.85 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.85 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Clobetasol SCHEMBL1651129 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL8602501 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL7616575 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL13046611 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL5034388 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL30915305 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL19327129 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL5034390 | 1.00 | NR3C1 (0.85) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Clobetasol SCHEMBL28167282 | 0.99 | NR3C1 (0.83) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 | |
| Dexamethasone SCHEMBL20770143 | 0.97 | HIF1A (0.92) | NR3C1CYP3A4HIF1AHSD17B10NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 21455 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260137657-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260139030-A1 | CHIMERIC PROTEINS FOR TREATING CUTANEOUS INFLAMMATION | SHATTUCK LABS INC (US) | 2026-05-21 | — | — | US | claimed |
| US-20260137656-A1 | METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS | SPARROW PHARMACEUTICALS INC (US) | 2026-05-21 | — | — | US | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260130899-A1 | METHOD OF TREATMENT FOR PREVENTION OF GLUCOCORTICOID TOXICITY AND/OR ENHANCEMENT OF MUSCLE REGENERATION VIA NEUTROPHIL ELASTASE INHIBITION | THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) | 2026-05-14 | — | — | US | claimed |
| EP-4741421-A1 | FAB-ARM EXCHANGE-PREVENTING FC VARIANTS FROM WHICH EFFECTOR FUNCTIONS ARE REMOVED | Korea University Research and Business Foundation (KR) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| EP-3222270-B1 | COMPOSITIONS FOR MUCOSAL ADHESION AND USES THEREOF | BIONANOPLUS S L (ES) | 2026-04-29 | — | — | EP | claimed |
| US-20260103492-A1 | CYCLOSPORINE COMPOSITIONS AND METHODS OF USE | BACAINN BIOTHERAPEUTICS, LTD. (KY) | 2026-04-16 | — | — | US | claimed |
| US-12599556-B2 | Ophthalmic compositions | BIOTHERAVISION INC. (US) | 2026-04-14 | — | — | US | claimed |
| US-4851521-A | Esters of hyaluronic acid | FIDIA, S.P.A. (IT) | 1989-07-25 | — | — | US | claimed |
| EP-0265116-A2 | Cross-linked esters of hyaluronic acid | FIDIA S.p.A. (IT) | 1988-04-27 | — | — | EP | claimed |
| CN-87104499-A | Novel alginic acid esters | — | 1988-04-06 | — | — | CN | claimed |
| EP-0251905-A2 | Esters of alginic acid | FIDIA S.p.A. (IT) | 1988-01-07 | — | — | EP | claimed |
| EP-0241134-A1 | Pharmaceutical mixture comprising nedocromil or a salt thereof in combination with a bronchodilator | FISONS plc (GB) | 1987-10-14 | — | — | EP | claimed |
| EP-0216453-A2 | Esters of hyaluronic acid and their salts. | FIDIA S.p.A. (IT) | 1987-04-01 | — | — | EP | claimed |
| EP-0197718-A2 | New medicaments for topical use | FIDIA S.p.A. (IT) | 1986-10-15 | — | — | EP | claimed |
| EP-0173478-A1 | Treatment of skin disorders | SCOTIA HOLDINGS PLC (GB) | 1986-03-05 | — | — | EP | claimed |
| EP-0068553-B1 | TOPICAL ANTIMICROBIAL ANTI-INFLAMMATORY COMPOSITIONS | THE PROCTER & GAMBLE COMPANY (US) | 1985-11-21 | — | — | EP | claimed |
| US-4333927-A | CORTICOSTEROID, PHOSPHATIDE, BUTYLHYDROXYANISOLE AND/OR BUTYLHYDROXYTOLUENE | MITSUBISHI CHEMICAL INDUSTRIES, LTD. (JP) | 1982-06-08 | — | — | US | claimed |